The great majority of penny companies fail. That's why so

New Post Public Reply Private Reply Replies (1) Message Board
microcaps Machiavelli10 #647
The great majority of penny companies fail. That's why so many entities, including even hedge funds,according to shorting experts, troll/short them to steal from retail,mostly the non-current pennies, for reasons I've detailed. The breakouts -the great successes- are rare.

I STRONGLY believe NNLX will be one of those rare breakouts/successes.

But thats exactly WHY NNLX needs to protect itself against shorters insurance policy-
their calling otc and alerting them to a promo to get a ce even when there is no promo- because otc dtc sec brokers etc believe ALL companies should be at least current otc- especially once they transition to revenues.

Shorters dont even have to call otc if otc sec etc itself sees pps rising in a non-current company.
In such, otc believes pps rise is due to a promo,as they personally told me, which they dont allow for non-current companies because they dont feel investors have enough vetted info to make a decision-and feel any such promo / email/ PR etc re progress is a fraud upon investors.
SEC/FBI/DTCC feels the same way
.

And its not about NNLX being able to raise funds-though a ce would greatly hamper that - because as they transition to revenues they wont need to raise funds,and its not about us needing financials because financials are largely irrelevant in this situation until substantial revenue.

The company I was in was a rare operational success transitioning to large revenues.Thats why pps was rising substantially as it eventually will do w NNLX- when NNLX's success becomes apparent to a larger crowd.

People have a tendency to reject what they dont understand or have not personally experienced,especially when its such a game like the ce game, but only 1 person openly opposed warning the company of the potential problem.

Besides, majority rule has nothing to do w rightness or accuracy. Before Copernicus everybody thought the sun revolved around the earth,but that didnt make it so.
The majority, including Einstein,opposed quantum mechanics because for decades it seemed incompatible w relativity until the unified field theory was largely validated.

What is the downside to warning the company-nothing.
IF the company understands it, unlike many here who have heard much more explanation than the company has received- the company can spare itself and longs much trouble and eliminate much of the shorter games at the same time.

The company has been warned as a result of my expose.Lets hope they understand more than most here.

Longs ,including myself, couldnt even believe what we were seeing as brokers dtc sec etc joined in the fray,and pps was pushed down to .0001 and then a global chill.
These things had never been seen before but its a common practice now. Due to political mandates by a politician who decided business was evil and had to be stopped the agencies are no longer longs friends,as Cramer has pointed out.

In fact, leaders of shorting cartels publicly say they are SEC informants,and publicly said the reason why they targeted our company was because our company was the only real company in the bunch of non-current companies targeted by others.

In a typical non-current company w no reasonable product or revenues a shorter attack will thus rapidly kill the stock- end of the milking game.

So shorters/mm's/brokers target a company with underlying fundamentals- like NNLX - because they can milk the cow over and over rather than immediately killing it.
Shorting cartel leaders have admitted this. So they and mm's (who reportedly often employ bashers- see the sticky posts- 40,86,117 of Maxs trading tips 101 board) and brokers run it down to their targeted pps and then let it rise to short again.



Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 2

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
AI and Workforce Transformation: Zellis Connect 2026

Updated Category News Views 0

AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...

Continue Reading
53% of European Telecom Users Eye Provider Switch

Updated Category News Views 3

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
Hyundai and UEFA: Kicking Off a Game-Changing Deal

Updated Category News Views 3

Hyundai Drives Into Europe's Football Arena Football fever just turned electric with Hyundai allying itself with the UEFA Champions League. We're not talking about sidelines. We're smack dab in the center field of a multi-year partnership starting with the 2026/27 season. Folks, if you think this is just Hyundai shaking hands for brand exposure, think again. This is...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 4

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 2

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
AION UT Sets New Safety Standard in Euro NCAP 2026

Updated Category News Views 1

The New Gold Standard in Safety for Small EVs Hop into your favorite auto forum and you'll hear more than a buzz—it's a full-blown ruckus. The reason? GAC’s AION UT just nabbed a 2026 Euro NCAP Five-Star Safety Rating. Now, this isn’t just another accolade in a crowded trophy room; it’s a statement, a seismic shift in how small electric vehicles stack up in terms...

Continue Reading
Sky Labs' CART Monitor Advances BP Monitoring Tech

Updated Category News Views 0

Cuffless BP Monitoring: Changing the Game for AF and HF Ever thought a finger ring could revolutionize blood pressure monitoring? Well, welcome to the future—Sky Labs' ring-type CART monitor has just rocked the scene at the ESC Congress 2026 in Munich. This isn't sci-fi, folks; it's where health tech meets reality, and it's shaking the very foundations of how we manage...

Continue Reading

Top 5 Most Recently Viewed Articles

Lynkwell Boosts Growth with Strategic Investments in North America

Updated Category News Views 191

Lynkwell Amplifies Growth Plans for North American Expansion Lynkwell, a leading player in energy infrastructure, is set to embark on an exciting journey into 2025. With a focus on meeting the growing demands of the evolving electric vehicle (EV) market, Lynkwell is making significant investments to enhance its capabilities and expand its footprint across North America....

Continue Reading
Understanding the Recent Private Student Loan Trends and Insights

Updated Category News Views 197

Overview of Recent Trends in Private Student Loans In the recent semi-annual Private Student Loan Report released by Enterval Analytics, insights into the current status of private student loans reveal a stable repayment landscape. Since Enterval focuses on the private student loan market, their findings shed light on how borrowers are adapting their financial strategies...

Continue Reading
StemCyte's Groundbreaking RMAT Designation for Long COVID-19

Updated Category News Views 63

StemCyte's Major Achievement in Cord Blood Therapy StemCyte has made significant strides in regenerative medicine, specifically with its Hematopoietic Progenitor Cell (HPC) Cord Blood therapy. The company recently announced that it has received the Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) aimed at treating...

Continue Reading
Novo Nordisk Restructures to Combat Rising Competition

Updated Category News Views 214

Novo Nordisk's Significant Job Cuts Novo Nordisk, a leading pharmaceutical company in diabetes care, has announced a major workforce reduction, cutting 9,000 jobs, which amounts to about 11.5% of its employees. This decision reflects the intense market pressure the company faces from its competitor, Eli Lilly. Restructuring for Financial Efficiency The restructuring...

Continue Reading
One Helix: The Innovative Research Hub Transforming Life Sciences

Updated Category News Views 169

Elevating Research with One Helix One Helix emerges as a landmark project in life sciences, representing a new era of innovation and sustainable architecture. Located within a prominent university medical center, this facility is not just a building; it is a commitment to fostering scientific advancements. Completely leased to AstraZeneca, One Helix is designed to elevate...

Continue Reading